Resultados de la búsqueda 311-320 of 1898 for Prepuce

  1. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to evaouate how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) ...

  2. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to compare the effects, good and/or bad of two treatment methods on subjects and their cancer. Proton beam radiation therapy is ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to design, develop and assess the performance characteristics of NGS assays using circulating tumor DNA for the detection of ...

  4. Oncología (médica) - Ensayos clínicos

    Chemotherapy drugs, such as capecitabine and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping ...

  5. Esguince: primeros auxilios - Mayo Clinic

    Mayo Clinic products and services · Libro: Mayo Clinic First-Aid Guide for the Outdoor Adventurer (Guía de primeros auxilios de Mayo Clinic para el aventurero al ...

  6. Oncología (médica) - Ensayos clínicos

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  7. Mayo Clinic

    Share · Tweet. March 03, 2020 . VID-20475717. Inicio; Spanish-Historias Mayo - Andres Hinojosa. Tu donación es muy poderosa... ¿quieres hacerla hoy mismo?

  8. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to examine how well ascorbic acid and combination chemotherapy work in treating patients with lymphoma that has come back or does ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. 99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer whose biopsy indicates ...

  10. Oncología (médica) - Ensayos clínicos

    The purpose of this study is for IMC-F106C plus nivolumab compared to standard nivolumab regimens in HLA-A*02:01-positive participants with previously untreated ...